Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
0913693 BCREPCF Market Cap is $0.01 Mil as of Jul. 21, 2026.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). 0913693 BC's share price for the quarter that ended in Sep. 2023 was $0.085. 0913693 BC's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 65.00 Mil. Therefore, 0913693 BC's market cap for the quarter that ended in Sep. 2023 was $5.53 Mil.
0913693 BC's quarterly market cap
declined
from Mar. 2023 ($7.15 Mil) to Jun. 2023 ($6.77 Mil) and
declined
from Jun. 2023 ($6.77 Mil) to Sep. 2023 ($5.53 Mil).
0913693 BC's annual market cap
increased
from Dec. 2020 ($5.70 Mil) to Dec. 2021 ($6.34 Mil) but then
declined
from Dec. 2021 ($6.34 Mil) to Dec. 2022 ($2.45 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. 0913693 BC's Enterprise Value for Today is $0.01 Mil.
0913693 BC (OTCPK:REPCF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
0913693 BC Market Cap Related Terms
0913693 BC Market Cap Historical Data
* Premium members only.
The historical data trend for 0913693 BC's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, 0913693 BC's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
0913693 BC Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 0913693 BC's Market Cap distribution charts can be found below:
* The bar in red indicates where 0913693 BC's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
0913693 BC's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
0913693 BC (REPCF) has a Market Cap of $0.01 Mil as of Jul. 21, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on 0913693 BC and its competitors.
Is 0913693 BC's Market Cap too high?
0913693 BC's current Market Cap is $0.01 Mil. The Biotechnology industry median Market Cap is 111.61. 0913693 BC's value of $0.01 Mil is 100% below this industry median.
How does 0913693 BC's Market Cap compare to VRTX and REGN?
0913693 BC's Market Cap of $0.01 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 111.61. 0913693 BC's value of $0.01 Mil is 100% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 111.61, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 0913693 BC's current Market Cap of $0.01 Mil is 100% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on 0913693 BC and its competitors. For the Biotechnology industry, the median Market Cap is 111.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 0913693 BC's current Market Cap is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 0913693 BC stock overvalued right now?
0913693 BC (REPCF) has a current Market Cap of $0.01 Mil. The current Market Cap is $0.01 Mil and 100% below the Biotechnology industry median of 111.61. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For 0913693 BC (REPCF), the current Market Cap is $0.01 Mil as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
0913693 BC Ltd is a regenerative medicine company focused on aesthetics and orthopedics. It is a royalty company that holds its primary royalty assets focused on autologous cell therapies that treat functional cellular deficits, including chronic tendon injuries, androgenetic alopecia, and skin aging. The Company is organized into one business unit based on its cell replication technology and has one reportable operating segment. Its product line is RCT-01 Tendon Repair, RCS-01 Skin Rejuvenation, RCH-01 Hair Growth, and DermaPrecise.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
REPCF has been successfully added to your 
